Premium
The density of infiltrating T cells and macrophages in the parental tumour correlates with growth rate of tumoroids established from colorectal adenocarcinoma
Author(s) -
Mousavi Nabi,
Jespersen Anna Josefine Bang,
Jorgensen Lars Nannestad,
Timmermans Vera,
Heegaard Steffen
Publication year - 2019
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/iep.12341
Subject(s) - cd68 , colorectal cancer , in vitro , cd3 , pathology , medicine , immune system , adenocarcinoma , immunohistochemistry , biology , cancer , cancer research , immunology , cd8 , biochemistry
Summary The aim of the present study was to investigate the correlation between the density of infiltrating T cells and macrophages in the parental colorectal cancer (CRC) and the growth rate of tumoroids (i.e. a patient‐derived in vitro 3D model). Tumoroids were established from fresh specimens of primary and metastatic CRC from 29 patients. The in vitro growth rate of tumoroids was monitored by automated imaging. The density of infiltrating T cells and macrophages was determined in the centre of the tumour (CT) and at the invasive margin (IM) of the parental tumours. This was performed by digital image analysis on the whole‐slide scanned images using Visiopharm ® software. Tumoroids with higher density of infiltrating CD3+ lymphocytes in the IM of their parental tumour showed a higher growth rate ( P < .0005). The average relative growth rate (log10) during the period from day 1 to day 11 was 0.364 ± 0.006 (mean ± SD) for the CD3+ (IM)‐high group and 0.273 ± 0.008 (mean ± SD) for the CD3+ (IM)‐low group. In contrast, the density of CD68+ infiltrating macrophages in the parental tumours showed significant inverse effect on the growth rate of the tumoroids ( P < .0005). The present study showed that the density of immune cells in the parental CRC correlates with the growth rate of the tumoroids. The future perspective for such a 3D model could be in vitro investigations of the tumour‐associated inflammatory microenvironment as well as personalized cancer immunotherapy.